Followers | 1074 |
Posts | 26122 |
Boards Moderated | 12 |
Alias Born | 01/11/2016 |
Friday, May 03, 2019 7:39:44 AM
Recent ABIO News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/07/2024 06:08:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 09:15:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 09:39:21 PM
- ARCA biopharma Announces 2023 Financial Results • GlobeNewswire Inc. • 02/01/2024 09:35:07 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/01/2024 09:15:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 11:39:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:25:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:25:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:25:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:25:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:25:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:25:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 09:15:13 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 12/19/2023 09:25:05 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 12/19/2023 09:20:02 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/19/2023 09:15:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 09:36:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/18/2023 08:35:08 PM
- ARCA biopharma Announces Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 10/18/2023 08:25:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/18/2023 08:15:25 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 09/11/2023 08:01:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/21/2023 08:35:49 PM
- ARCA biopharma Announces Second Quarter 2023 Financial Results • GlobeNewswire Inc. • 07/21/2023 08:25:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/21/2023 08:16:06 PM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM